#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine cell hyperplasia of infancy B-cell lymphoma refractory Isodicentric chromosome 15 syndrome Facioscapulohumeral muscular dystrophy Mantle cell lymphoma refractory Leber's congenital amaurosis Squamous cell carcinoma of head and neck Adenocarcinoma pancreas Thrombotic thrombocytopenic purpura Ocular myasthenia Short stature homeobox gene mutation Extra-osseous Ewing's sarcoma Neoplasm Ataxia telangiectasia Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS Small intestine leiomyosarcoma – Basic Information Turner’s syndrome – Treatment Mantle cell lymphoma refractory – Trials in Disease Crigler-Najjar syndrome – Treatment Idiopathic pulmonary fibrosis Soft tissue sarcoma – Life with Disease Indolent systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Perampanel Quinine Dihydrochloride Pramipexole Ds-3939A VX-993 Urokinase Radiprodil Calcium Pomalidomide AZD0022 Izaflortaucipir (18F) GSKVX000000030918 Ambrosia Artemisiifolia (302) Fitusiran MB-CART2219.1 Guanfacine Doconexent Aprepitant Benzylpenicillin ANXV More therapies…

    Learn about Your Condition

    Pigmentary glaucoma Mesothelioma Cardiogenic shock Congenital aplastic anaemia Clostridium difficile colitis Bronchostenosis Liver disorder Metastases to biliary tract Hypochondroplasia Naevus flammeus Intracranial aneurysm Retroperitoneal fibrosis Herpes zoster Tympanic membrane perforation Dupuytren's contracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer…

Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

54 Rue Henri Sainte Claire Deville, Toulon, 83100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Paclitaxel
    France

  • Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Carboplatin
    Austria Belgium France Germany Italy The Netherlands +2

  • Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Embolism venous
    Investigated Drugs:
    • Abelacimab
    • Apixaban
    Austria Czechia France Germany Hungary Ireland +6

  • Study Comparing Venetoclax and Obinutuzumab with Drug Combination for Fit Patients with Untreated Chronic Lymphocytic Leukemia Without Specific Genetic Mutations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Venetoclax
    • Bendamustine Hydrochloride
    • Cyclophosphamide Monohydrate
    France Italy Spain

  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Gastrointestinal cancer metastatic
    • Embolism venous
    Investigated Drugs:
    • Abelacimab
    • Dalteparin Sodium
    Austria Czechia France Germany Hungary Ireland +6

  • Study of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Capecitabine
    • Fluorouracil
    France

  • Study on the Effectiveness of Dexamethasone Implant for Patients with Diabetic Macular Edema

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dexamethasone
    France

  • Study Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    • Cisplatin
    France

  • Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    France
Previous Page
1 … 3 4 5 6 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!